In the previous post, I talked about the demand for developing new payment plans especially for gene therapies. Then, I came across a...

My summary of an article from BCG titled "From Lab to Marketplace, Succeeding with Gene Therapies", which taught me that I should look at...

Summary of a Nature Biotechnology article titled "Big pharma buys into exosomes for drug delivery": What problems could exosomes solve?...

A couple of days ago when I heard that Amazon launched online pharmacy, I wrote a short post pointing out that Alexa, physical spaces...

This Nature Review Drug Discovery article looks like and is about RNA therapeutics, but what jumped out at me was the importance of the...

(Just to update my previous post about the liquid biopsy) Two recently approved liquid biopsy diagnostic tests paired with...

Early cancer detection tools mostly involve circulating DNA (or cell-free DNA (cfDNA)) in the bloodstream. For instance, companies, such...

Another research has identified long non-coding RNAs (lnc RNAs) that are involved in cancer--TROLL-2 and TROLL-3--adding them to a...

In the list of upcoming IPOs, I saw a biotech company called Taysha Gene Therapies. The company's gene therapy programs haven't entered...

This WSJ article was about electric-vehicle startups, but what drew my attention was, of course, biotech counterparts. The green circles...

CB Insights’ Game Changers 2020 report features three biotech companies under the CRISPR 2.0 category. The report describes CRISPR 2.0 as...